Introduction {#s1}
============

Esophageal cancer (EC) is the sixth most common cancer worldwide with 5-year survival rate less than 10% and occurs at a relatively high frequency in certain areas of China [@pone.0065742-Umar1], [@pone.0065742-He1]. Esophageal Squamous Cell Carcinoma (ESCC) is the major type of EC in China, and the mechanism of ESCC still remains unclear. Many factors may increase the risk of ESCC, including environmental and genetic factors. Several studies have found out that DNA repair efficiency in cancer patients is lower than that of normal people, and the variants of the genes involved in DNA repair can lead to increasing risk of cancer [@pone.0065742-Mohrenweiser1]. The human 8-oxoguanine glycosylase 1 (hOGG1) gene, located on chromosome 3, encodes 8-hydroxygumine DNA glycosylase 1 (OGG1) that can repair damaged DNA by excising 8-dihydro-8-oxoguanine (8-OH-G) [@pone.0065742-Dherin1]. Genetic variations in hOGG1 gene may alter glycosylase activity, increasing the cancer risk [@pone.0065742-Audebert1]. There are several polymorphisms in the hOGG1 gene [@pone.0065742-Nishioka1]; and Ser326Cys polymorphism has attracted widespread attention. With a Ser to Cys amino acid substitution at codon 326, Ser326Cys can affect the function of hOGG1. This variation maybe associated with risk of cancer. A study indicated that compared to the 326Cys variant enzyme, the 326Ser enzyme of hOGG1 has a higher activity [@pone.0065742-Kohno1]. Many studies have focused on the association of Ser326Cys polymorphism in hOGG1 and ESCC risk, including several case-control studies [@pone.0065742-Hall1]--[@pone.0065742-Xing1]. However, the results of these studies remained inconclusive and inconsistent. In this meta-analysis, by searching individual dataset from all eligible case-control studies published to date, we aimed to estimate the role of hOGG1 Ser326Cys polymorphism in the risk of ESCC as well as to quantify the between-study heterogeneity and potential bias.

Materials and Methods {#s2}
=====================

Identification and Eligibility of Relevant Studies {#s2a}
--------------------------------------------------

To identify all published studies that examined the association of hOOG1 Ser326Cys polymorphism with ESCC risks, we conducted a computerized literature search of following databases: PubMed, Web of Science, Medline, China Knowledge Resource Integrated Database (CNKI) and Wanfang database. The key words were as follows: ("esophageal cancer" OR "oesophageal cancer" OR "ESCC"), ("OGG1" OR "hOGG1" OR "8-Oxoguanine DNA glycosylase 1"), and ("polymorphism" OR "variation" OR "mutation" OR "SNP"). In the CNKI and Wanfang, corresponding Chinese characters of the keywords were used for searching. References of retrieved articles were also screened. When a study reported results on different subgroups, we treated each subgroup as a single comparison in the meta-analysis. Studies included in this meta-analysis should meet the following criteria: firstly, evaluate the association between hOGG1 Ser326Cys polymorphism and ESCC risk; secondly, use a case-control design; thirdly, contain available genotype frequency or genotype frequency can be calculated. Additionally, other relevant studies were identified by hand-searching the references of the eligible articles.

Data Extraction {#s2b}
---------------

Two investigators independently extracted data and reached a consensus on all the items. For each study, the following data were included: the last name of first author, the year of publication, the DNA source of patients (from blood or tumor tissue), ethnicity, the source of controls (population- or hospital-based), genotyping method, numbers of patients and controls, genotypes distribution in each group and published language. We also tested Hardy-Weinberg equilibrium (HWE) of genotypes distribution in control groups.

Statistical Analysis {#s2c}
--------------------

We examined hOGG Ser326Cys genotypes under the dominant (Cys/Cys+Cys/Ser vs. Ser/Ser), recessive (Cys/Cys vs. Cys/Ser+Ser/Ser), and additive (Cys/Cys vs. Cys/Ser vs. Ser/Ser) models.

The strength of the association between the hOGG1 Ser326Cys polymorphism and ESCC susceptibility was measured by odds ratios (ORs) with 95% confidence intervals (CIs). In the dominant and recessive model, the statistical significance of the summary OR was determined with the Z test. Heterogeneity assumption was checked by the Q test [@pone.0065742-Handoll1]. If the p-value was greater than 0.1, a random effect model was used to pool the results. Otherwise, a fixed effects model was then used [@pone.0065742-Mantel1], [@pone.0065742-DerSimonian1]. In the additive model, in order to identify the association between the ESCC risk and the number of copies of the 326Cys allele (0, 1 or 2), Cochran-Armitage trend test was used to calculate p-value for each study [@pone.0065742-Cochran1], [@pone.0065742-Armitage1]. Greenland and Longnecker\'s method was used to give the result of overall studies [@pone.0065742-Greenland1].

Stratified analyses were performed by published language (English or Chinese), ethnicity (Asian or Caucasian), source of controls (population- or hospital-based) and the DNA source of patients (blood or tumor tissue).

Meta-regression models were also employed to evaluate the different variance among the individual ORs when heterogeneity was detected. Potential sources of heterogeneity were: published language, ethnicity of the population, source of control and the source of patient DNA.

In order to analyze the deviation of the single study that may denote bias to the overall results, all studies were subjected to a sensitivity analysis. If a study affected the overall result significantly, comprehensive analysis would be taken to find out the cause of heterogeneity. Once found significant heterogeneity, we would like to find out the reason that causes the heterogeneity in the following analysis. Study that deviated from HWE was also removed, for investigating the affection for the overall results. Furthermore, in order to track evidence over time, we also performed a cumulative meta-analysis, in which studies were chronologically ordered by publication year, and pooled ORs were calculated at the end of each year. Funnel plots and Egger' s linear regression test were used to provide diagnosis of the potential publication bias [@pone.0065742-Egger1]. Results were regarded as statistically significant if P\<0.05. All statistical tests were performed with Review Manage, version 5.2 and R, version 2.14.1 using two-sided p-values.

Results {#s3}
=======

Characteristics of Studies {#s3a}
--------------------------

There were 40 articles relevant to the search words after removing duplicates records. By reading the titles and abstracts, 23 articles were excluded. Besides, we reviewed the full texts and removed 4 articles because they are not related to our research or not case-control designs. Moreover, we found an article consists of two study groups, so we treated it as two studies in our analysis. Then we checked the type of esophageal cancer and the information about the number of ESCC patients. In this stage, we found that two studies were not related to ESCC, but esophageal adenocarcinoma (EAC) [@pone.0065742-Ferguson1], [@pone.0065742-Tse1]. Another two studies contain both types of EC: EAC and ESCC, but we can't get the numbers of ESCC patients even after contacting authors [@pone.0065742-Lagadu1], [@pone.0065742-Gao1]. Finally, according to our inclusion criteria, a total of 10 eligible studies, including 6 English articles [@pone.0065742-Hall1]--[@pone.0065742-Xing1] and 4 Chinese studies [@pone.0065742-Hu1]--[@pone.0065742-Zhu1], involving 1987 cases and 2926 controls were enrolled in the pooled analyses ([Table 1](#pone-0065742-t001){ref-type="table"}). Among 4 Chinese articles, one of them only has Chinese title and abstract (we have translated the title into English) [@pone.0065742-Hu1], others have both the title and abstract in English. The flow chart of literature search and study selection was illuminated in [Figure 1](#pone-0065742-g001){ref-type="fig"}. These studies were conducted in different populations of various ethnicities: 6 studies of Chinese, 1 study of European, 2 studies of Indian and 1 study of Kazakh. Control sources were from 6 population-based and 4 hospital-based. DNA of the patients were extracted from different source, 7 studies from blood and 3 studies from tissue. In addition, genotype distribution of the control group in one study was not consistent with HWE.

![Flow diagram of the study selecting process.](pone.0065742.g001){#pone-0065742-g001}

10.1371/journal.pone.0065742.t001

###### Characteristics of studies included in this meta-analysis.

![](pone.0065742.t001){#pone-0065742-t001-1}

  Fist author                                    Year   Published language                  Ethnicity                   Source of Controls   DNA Source of patients   Genotyping method   p for HWE   Genotypes of Cases   Genotype of Controls                   
  --------------------------------------------- ------ -------------------- ------------------------------------------ -------------------- ------------------------ ------------------- ----------- -------------------- ---------------------- ---- ----- ----- ----
  Hall                                           2006        English         European[b](#nt102){ref-type="table-fn"}        Hospital                blood                 Taqman           0.061            107                    56            10   622   320   27
  Hao                                            2004        English                         Chinese                        population               blood                PCR-RFLP          0.250            153                   180            77   184   216   79
  Hu                                             2010        Chinese                         Chinese                        population               tissue               PCR-RFLP          0.096             88                    93            54   80    120   28
  Li                                             2011        English                         Chinese                         Hospital                blood                PCR-SSCP          0.154             86                   126            13   97    123   26
  Liu                                            2005        Chinese                         Chinese                         Hospital                blood                PCR-CTPP          0.682             16                    57            33   21    50    35
  Upadhyay(K)[a](#nt101){ref-type="table-fn"}    2010        English                          Indian                        population               blood                PCR-CTPP          0.128             59                    66            10   94    89    12
  Upadhyay(U)[a](#nt101){ref-type="table-fn"}    2010        English                          Indian                        population               blood                PCR-CTPP          0.020             84                    97            19   96    100   11
  Wang                                           2009        Chinese                          Kazakh                         Hospital                blood                 PCR-LDR          0.338             30                    61            28   26    50    16
  Xing                                           2001        English                         Chinese                        population               tissue               PCR-SSCP          0.154             78                    76            42   68    106   27
  Zhu                                            2009        Chinese                         Chinese                        population               tissue               PCR-SSCP          0.981             67                    85            36   80    95    28

Two groups in this article, K means Kashmiri, U means Uttar Pradesh;

Romania, Poland, Russia, Slovakia and Czech.

**Abbreviations:** HWE: Hardy--Weinberg equilibrium; S/S: Ser/Ser; S/C: Ser/Cys; C/C: Cys/Cys.

Quantitative Synthesis {#s3b}
----------------------

We carried out a meta-analysis of the hOGG1 Ser326Cys polymorphism overall, and in subgroups according to ethnic groups, published languages, DNA source of patients and the source of controls. Results of the recessive and dominant model are shown in [Table 2](#pone-0065742-t002){ref-type="table"} and [Table S1](#pone.0065742.s003){ref-type="supplementary-material"}, respectively. Forest plots are shown in [Figure 2](#pone-0065742-g002){ref-type="fig"}. There was a significant association between the hOGG1 Ser326Cys and ESCC risk in the overall analysis in the recessive model (OR = 1.37, 95% CI 1.06--1.76, P = 0.02). However, the result was not significant under a dominant model (OR = 1.06, 95% CI: 0.94--1.20; P = 0.36). There was significant heterogeneity between studies under the recessive model (P = 0.06; I^2^ = 45%) but not the dominant model (P = 0.87; I^2^ = 0%). In subgroup analysis, the hOGG1 Cys/Cys polymorphism was significantly associated with the risk of ESCC in the recessive model performed by ethnicity, published language, DNA source of patients and the source of control groups. We found that Cys/Cys variants in subgroups of Chinese language, Caucasian, controls of population and tissue increased ESCC risks, with the ORs of 1.49 (95% CI 1.12--1.96, p = 0.006), 1.64 (95% CI 1.12--2.40, p = 0.01), 1.50 (1.22--1.85, p = 0.0001), 1.79 (1.33--2.42, p = 0.001), respectively. However, no significant result was observed in the dominant model in any subgroup. In the additive model, pairwise comparison of genotypes and p-value of the Cochran-Armitage test for each study are shown in [Table S2](#pone.0065742.s004){ref-type="supplementary-material"}. Overall and subgroup results are shown in [Table S3](#pone.0065742.s005){ref-type="supplementary-material"}. Positive correlation was found between the number of Cys allele and the risk of ESCC (PCC = 0.109, SE = 0.046, p = 0.02). In subgroup analysis, the risk of ESCC is positively correlated with the number of Cys allele in Caucasian subgroup (PCC = 0.19, SE = 0.084, p = 0.02) and population subgroup (PCC = 0.12, SE = 0.055, p = 0.03). No heterogeneity was found between studies (P = 0.94; I^2^ = 0%).

![Forest plots of odds ratios (ORs) with 95% confidence limits (CIs).\
The center of each square represents the OR. The area of the squares reflects the weight, and the horizontal line indicates the 95% CI. (A). recessive model; (B). dominant model.](pone.0065742.g002){#pone-0065742-g002}

10.1371/journal.pone.0065742.t002

###### Quantitative analyses and the test of heterogeneity of the hOGG1 Ser326Cys polymorphism on the ESCC risk in a recessive model.

![](pone.0065742.t002){#pone-0065742-t002-2}

                        Q-test                                             
  -------------------- -------- --- ------ ------ ------ ----------------- --------------------------------------
  Overall               16.26    9   0.06    45    4913   1.37(1.06,1.76)   0.02[b](#nt105){ref-type="table-fn"}
  Ethnic group                                                             
  Asian                 13.75    5   0.02   63.6   2823   1.25(0.88,1.77)   0.21[b](#nt105){ref-type="table-fn"}
  Caucasian              1.16    3   0.76    0     2090   1.64(1.12,2.40)                   0.01
  Published language                                                       
  English language      10.97    5   0.05   54.4   3636   1.31(0.90,1.90)   0.16[b](#nt105){ref-type="table-fn"}
  Chinese language       4.7     3   0.2    36.1   1277   1.49(1.12,1.96)                  0.006
  Source of controls                                                       
  Population             4.75    5   0.45    0     2877   1.50(1.22,1.85)                  0.0001
  Hospital               8.64    3   0.03   65.3   2036   1.09(0.62,1.93)   0.77[b](#nt105){ref-type="table-fn"}
  DNA source                                                               
  blood                 10.37    6   0.11   42.2   3662   1.15(0.93,1.44)                   0.2
  tissue                 0.95    2   0.62    0     1251   1.79(1.33,2.42)                  0.0001

Sample size equals the total number of controls and cases;

Caculated by random model, otherwise by fixed model.

**Abbreviations:** OR: odds ratio; CI: confidence intervals.

Meta-regression analysis under the recessive model was performed in order to find out potential sources of heterogeneity. Empty regression was firstly run to estimate the baseline value for tau^2^ (0.070). In the meta-regression analysis, the model including DNA source of patients reduced the tau^2^ value to 0.014 (beta coefficient = 1.993, 95% CI: 0.007--0.832; P = 0.046), suggesting DNA source of patients was a significant source of heterogeneity in the recessive model.

Sensitivity Analyses and Adjusted Results of Meta-analysis {#s3c}
----------------------------------------------------------

Since significant heterogeneity across studies was observed for the recessive model, we conducted a sensitivity analysis to assess the influence of each individual study on the pooled OR and the heterogeneity by sequentially removing the individual study. Results are summarized in [Table 3](#pone-0065742-t003){ref-type="table"}. The forest plot of sensitivity analysis in a random model is shown in [Figure 3](#pone-0065742-g003){ref-type="fig"}. We can see that removing the HWE-deviation study (Upadhyay 2010 "UP" population) did not affect the result significantly. We also found that the study conducted by Li et al. (2011) influents the overall pooled estimates and the heterogeneity most. We compared this study to other studies carefully and finally found a significant difference of sex and age between the case and the control in this study. The sex and age information for each study is listed in [Table 4](#pone-0065742-t004){ref-type="table"}. Cases and controls matched by sex and age in most studies. However, in the study of Li et al. (2011), we observed a significant difference between the case and control both by sex (p\<0.001) and age (p\<0.001). Besides, sex ratios between the case and control group in the study of Hall et al. (2006) were not matched well (p\<0.001). However, in the sensitivity analysis, this article did not influent the heterogeneity very much. This time, after omitting the Li et al. (2011), the overall heterogeneity between studies was not significant (P = 0.40, I^2^ = 3.8). These results proved that the study of Li et al. (2011) has a significant heterogeneity from other studies. After removing the study of Li et al. (2011), overall and subgroups ORs in 9 studies were calculated again in the recessive model. Results are summarized in [Table S4](#pone.0065742.s006){ref-type="supplementary-material"}. No significant heterogeneity was found in any subgroups. Results were in fixed models and the overall OR = 1.45 (95% CI 1.21--1.74, p\<0.0001, [Figure 4](#pone-0065742-g004){ref-type="fig"}). Comparing the former subgroups analysis, results had some changes. As shown in [Table S4](#pone.0065742.s006){ref-type="supplementary-material"}, all results of subgroups reached significant levels. Then, a new sensitivity analysis was performed on the remained 9 studies. Before and after deleting each study, no significant heterogeneity between the remaining studies was found ([Table S5](#pone.0065742.s007){ref-type="supplementary-material"}). Forest plot of sensitivity analysis in the fixed model is shown in [Figure S1](#pone.0065742.s001){ref-type="supplementary-material"}. The outcomes were all similar after removing each study. These results suggest that no individual study significantly affected the overall OR in the new meta-analysis.

![Results of odds ratios (ORs) with 95% confidence limits (CIs) in sensitivity analysis.\
Results were computed by omitting each study. Random-effects estimates were used. Each OR means the result when remove the corresponding study.](pone.0065742.g003){#pone-0065742-g003}

![Forest plots result without the study of Li et al.\
The center of each square represents the OR, the area of the square is the weight used in the meta-analysis, and the horizontal line indicates the 95% CI.](pone.0065742.g004){#pone-0065742-g004}
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###### Sensitivity analysis of 10 studies (recessive model).

![](pone.0065742.t003){#pone-0065742-t003-3}

                                                       Fix Model        Random model     heterogeneity                               
  ----------------------------------------------- -------------------- -------------- -------------------- ---------- ------- ------ ------
  None                                             1.348(1.130,1.608)      0.001       1.366(1.062,1.756)    0.015     0.070   44.7   0.06
  Hall 2006                                        1.318(1.099,1.580)      0.003       1.316(1.013,1.709)    0.040     0.070   45.7   0.06
  Hao 2004                                         1.416(1.153,1.740)      0.001       1.404(1.047,1.884)    0.024     0.094   47.8   0.05
  Hu 2010                                          1.257(1.040,1.520)      0.018       1.282(0.996,1.651)    0.054     0.053   36.8   0.12
  Li 2011                                          1.451(1.207,1.744)     \<0.0001     1.458(1.206,1.763)   \<0.0001   0.003   3.8    0.40
  Liu 2005                                         1.403(1.165,1.689)     \<0.001      1.431(1.099,1.865)    0.008     0.069   44.1   0.07
  Upadhyay 2010[a](#nt107){ref-type="table-fn"}    1.354(1.130,1.621)      0.001       1.377(1.050,1.805)    0.021     0.083   50.6   0.04
  Upadhyay 2010[b](#nt108){ref-type="table-fn"}    1.322(1.103,1.586)      0.003       1.332(1.019,1.741)    0.036     0.078   48.6   0.05
  Wang 2009                                        1.340(1.116,1.609)      0.002       1.357(1.029,1.790)    0.031     0.086   50.7   0.04
  Xing 2001                                        1.303(1.080,1.572)      0.006       1.322(1.003,1.743)    0.048     0.080   47.5   0.05
  Zhu 2009                                         1.333(1.105,1.607)      0.003       1.352(1.018,1.796)    0.037     0.090   50.5   0.04

Kashmiri population;

Uttar Pradesh population.

**Abbreviations:** OR: odds ratio; CI: confidence intervals; HWE: Hardy--Weinberg equilibrium.

10.1371/journal.pone.0065742.t004

###### Sex and age information extracted from original articles.

![](pone.0065742.t004){#pone-0065742-t004-4}

  First author                    Year                   Sex    Age                                                                                     
  -------------- -------------------------------------- ------ ------ ------ ------ --------------------------------------- ------------- ------------- -------------------------------------------
  Hall                            2006                   713     98    831    252                  p\<0.001                   \<50∶ 140     \<50∶ 203                    p = 0.095
                                                                                                                             50--54∶148    50--54∶170   
                                                                                                                             55--59∶155    55--59∶178   
                                                                                                                             60--64∶142    60--64∶174   
                                                                                                                             65--69∶ 106   65--69∶ 162  
                                                                                                                             70--74∶ 99    70--74∶ 149  
                                                                                                                               ≥75∶21        ≥75∶47     
  Hao                             2004                   N.A.   N.A.   N.A.   N.A.   match[a](#nt110){ref-type="table-fn"}      N.A.          N.A.         match[a](#nt110){ref-type="table-fn"}
  Hu                              2010                   171     64    167     61                  p = 0.907                 61.60±10.06   61.57±10.17                   p = 0.974
  Li                              2011                   162     64    125    121                  p\<0.001                    \<50∶38      \<50∶142                     p\<0.001
                                                                                                                             50--60∶102     50--60∶66   
                                                                                                                               ≥60∶86        ≥60∶38     
  Liu                             2005                    52     54     52     54                  p = 1.000                    N.A.          N.A.         match[a](#nt110){ref-type="table-fn"}
  Upadhyay        2010[b](#nt111){ref-type="table-fn"}    92     43    139     56                  p = 0.541                 60.38±8.40    57.98±12.66                   p = 0.055
                                2010^c^                  147     53    152     55                  p = 0.987                 56.52±12.09   55.41±10.35                   p = 0.300
  Wang                            2009                    80     52     83     50                  p = 0.763                    N.A.          N.A.         match[a](#nt110){ref-type="table-fn"}
  Xing                            2001                   140     56    143     58                  p = 0.950                  55.8±9.0      55.5±8.6                     p = 0.734
  Zhu                             2009                   105     83    126     77                  p = 0.212                    61.03         60.77      p = 0.061[a](#nt110){ref-type="table-fn"}

Described in the original article;

in Kashmiri population; c: in Uttar Pradesh population.

**Abbreviations:** N.A: Not Available.

Cumulative Meta-analysis and Publication Bias {#s3d}
---------------------------------------------

Cumulative meta-analysis of hOGG1 ser326cys with ESCC was conducted via the assortment of studies by publication time. Inclinations towards significant association were evident over time in the recessive model ([Figure 5](#pone-0065742-g005){ref-type="fig"}), but not in the dominant model ([Figure S2](#pone.0065742.s002){ref-type="supplementary-material"}). These results suggest that the precision of the estimates was progressively boosted by continually adding more samples.

![Forest plots of results of cumulative meta-analysis by published year in the recessive model.\
Pooled odds ratios (ORs) with 95% confidence limits (CIs) at the end of each information step were shown.](pone.0065742.g005){#pone-0065742-g005}

Funnel plot and Egger\'s test were performed to assess publication bias. The shapes of the funnel plots indicate that there was no obvious asymmetry. And the Egger\'s test also shows no publication bias (recessive: t = 0.27, p = 0.79; dominant: t = 0.91, p = 0.39; [Figure 6](#pone-0065742-g006){ref-type="fig"}).

![Begg's funnel plot with 95% confidence limits (CIs) of publication bias test.\
(A). recessive model; (B). dominant model.](pone.0065742.g006){#pone-0065742-g006}

Discussion {#s4}
==========

Oxidative DNA damage occurs in a cell when the production of reactive oxygen species (ROS) exceeds the cell's antioxidant-defense capacity, leading to cell apoptosis and producing mutations in the DNA [@pone.0065742-Roy1], [@pone.0065742-Yoshie1]. Among many factors of oxidative DNA damage, 8-hydroy-2-deoxyguanine (8-OHdG) is one of the most abundant oxidative products of highly mutagenic because of its propensities to mispair with adenine during DNA replication and to cause ultimately GC to TA mutation [@pone.0065742-Shibutani1].

Many studies have reported that the hOGG1 gene could remove 8-OHdG from DNA by base excision repair (BER) pathway [@pone.0065742-Boiteux1], [@pone.0065742-Boiteux2]. If hOGG1 was dysfunctional, the damage could be left unrepaired, leading to mutations or carcinogenesis. A polymorphism of the hOGG1 has been identified, which caused an amino substitution from serine to cysteine in a codon 326. A number of studies have suggested that this variation may be associated with increased risks of several kinds of cancer. Several of them have focused on the association between the hOGG1 Ser326Cys polymorphism and esophageal cancer risk, but the results were inconclusive. Hence, this meta-analysis was needed to provide a quantitative approach for combining the different results.

The present meta-analysis includes 1987 esophageal cancer cases and 2926 controls. As far as we know, this is the first meta-analysis carried out with the aim of investigating the relationship between hOGG1 Ser326Cys polymorphism and ESCC risks. Results were significant in the recessive and additive model. Comparing with the Ser/Ser and Ser/Cys genotype, Cys/Cys genotype might contribute to increase the risk of ESCC. And the ESCC risk is positively correlated with the number of Cys allele.

When taking the sensitivity analyses, we found an article that inference the overall result very much and have heterogeneity to other studies. When we remove this study, the heterogeneity disappeared and the results became more stable. By comparing this article to others, we finally found the sex rate and age in the case group were significantly different from those in the control group. Some studies have found that ESCC most often occurs in men, and more often seen in aged 50--70 [@pone.0065742-Bahmanyar1], [@pone.0065742-Johnell1]. These results suggest that when designing a case-control study of genetic polymorphism and cancer risk, investigator should match case and control well in sex rate and age, in order to give a reliable conclusion.

In many previous studies of meta-analysis, HWE-deviation studies were often ignored in the pooled estimate. However, a researcher argued that studies that appear to deviate from HWE should not be excluded unless there are other grounds for doubting the quality of the study [@pone.0065742-Minelli1]. In the sensitivity analysis of our research, no significant change of the OR was found when we remove the HWE-deviation study (Upadhyay 2010 "UP" Population). This result was consistent with that article. Therefore this study was included in our research.

In subgroup analysis by esophageal cancer types, we found that the hOGG1 Ser326Cys polymorphism was significantly associated with ESCC in the Caucasian population. However, the number of studies in this subgroup was a little small (n = 4), which may reduce the reliability of the results. Interestingly, we found a significant association between hOGG1 Ser326Cys polymorphism and ESCC in population controls group rather than controls based on the hospital. This finding suggests that Cys/Cys carrier may also cause other diseases risks in addition to ESCC.

In conclusion, our meta-analysis suggests that the hOGG1 Ser326Cys polymorphism is associated with esophageal cancer susceptibility. Cys/Cys carriers have more risk on ESCC rather than Ser/Ser and Ser/Cys carriers. Each copy of Cys modifies the risk of ESCC in an additive form. It is the homozygous Cys/Cys have a higher risk than heterozygous Cys/Ser. Moreover, in order to get a more reliable result, some factors such as gender and age should be matched in a case-control design study.

Several limitations of this meta-analysis should be addressed. First, we abandoned 2 studies when we read the full text of articles because they are mixed cancer types (EAC and ESCC); but we cannot get the numbers of ESCC patients from studies or authors. This limited the scale of the data to the meta-analysis. Second, genotypes errors may also influence the results, because the quality control of genotypic was not well documented in some studies. Third, several studies had a relatively small sample size.

In order to provide a more precise estimation, further research is necessary to use standardized unbiased homogenous cancer patients and well-matched controls to investigate the combined effects. That would lead to a better, comprehensive understanding of the association between hOGG1 Ser326Cys polymorphism and esophageal cancer risk.
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